What could you do with a SARRP? Take a look at some of the amazing research being presented at AACR 2016 with the help of this cutting edge equipment.
Presentations by SARRP Users
Molecular radiotherapy: Intracellular targets and delivery
Saturday, Apr 16, 2016, 8:00 AM – 8:25 AM – Katherine Vallis
Antibodies Targeted to Radiation Inducible Antigens in Cancer.
Saturday, Apr 16, 2016, 9:30 AM – 9:55 AM – Dennis Hallahan
Emerging evidence on how to best use radiation when combined with immune checkpoint blockade.
Saturday, Apr 16, 2016, 10:15 AM -10:40 AM – Silvia Formenti
Fundamental concepts and future strategies for combining radiation with immunotherapy therapy.
Saturday, Apr 16, 2016, 11:45 AM -12:10 PM – Samir Khlief
Resistance to targeted therapy: Guiding principles and new mechanisms.
Monday, Apr 18, 2016, 1:10 PM – 1:35 PM – Levi Garraway
The interplay of radiotherapy with the tumour microenvironment: Novel opportunities to overcome adaptive resistance.
Tuesday, Apr 19, 2016, 1:40 PM – 2:05 PM – Tim Illidge
The future of combinations of immunomodulators with local radiation: toward a personalized immunotherapy approach.
Tuesday, Apr 19, 2016, 2:10 PM – 2:35 PM – Sandra Demaria
Tumor mutation status will predict metabolic response to metformin in lung cancer treated with stereotactic body radiation therapy (SBRT).
Tuesday, Apr 19, 2016, 8:00 AM – 12:00 PM Thomas Guerrero
Posters developed with the help of SARRP
1664/21 Alpha-tocopheryloxyacetic acid (aTEA) induced immune activation synergizes with radiation therapy to treat primary and metastatic murine mammary carcinoma.
Monday, Apr 18, 2016, 8:00 AM -12:00pm
4985/9 Radiation potentiates systemic anti-tumor immunity unleashed by a novel TLR9 agonist (SD-101).
Wednesday, Apr 20, 2016, 8:00 AM -12:00 PM
3994/3Immune competent syngeneic models demonstrate additive effects of combination strategies using checkpoint immunotherapy and inducers of immunogenic cell death (ICD).
Tuesday, Apr 19, 2016, 1:00 PM – 5:00 PM
4987/11 Role of the PD-1/PDL-1 pathway in resistance of patients with metastatic breast cancer to treatment with radiotherapy and TGFß neutralization.
Wednesday, Apr 20, 2016, 8:00 AM -12:00 PM
1662/19 Development of a novel mouse model to study image-guided radiation-induced gastrointestinal injury and its application in pre-clinical research.
Monday, Apr 18, 2016, 8:00 AM -12:00 PM
4986/10 Regulation of radiation-induced in situ tumor vaccination by TGFß superfamily members.
Wednesday, Apr 20, 2016, 8:00 AM -12:00 pm
1416/17 Peritumoral IL-15 potentiates radiation-induced anti-tumor immunity.
Monday, Apr 18, 2016, 8:00 AM – 12:00 PM
